These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11898537)

  • 1. Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.
    Molho ES; Factor SA
    Curr Neurol Neurosci Rep; 2001 Jul; 1(4):320-8. PubMed ID: 11898537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combating psychosis in Parkinson's disease patients: the use of antipsychotic drugs.
    Chou KL; Fernandez HH
    Expert Opin Investig Drugs; 2006 Apr; 15(4):339-49. PubMed ID: 16548784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone treatment of drug-related psychosis in patients with parkinsonism.
    Leopold NA
    Mov Disord; 2000 Mar; 15(2):301-4. PubMed ID: 10752580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Friedman JH; Jacques C; Rosenfeld M
    Mov Disord; 1999 May; 14(3):484-7. PubMed ID: 10348474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
    Ruggieri S; De Pandis MF; Bonamartini A; Vacca L; Stocchi F
    Clin Neuropharmacol; 1997 Jun; 20(3):204-9. PubMed ID: 9197942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening of motor features of parkinsonism with olanzapine.
    Molho ES; Factor SA
    Mov Disord; 1999 Nov; 14(6):1014-6. PubMed ID: 10584679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine for the treatment of psychosis in Parkinson's disease: a review.
    Auzou P; Ozsancak C; Hannequin D; Moore N; Augustin P
    Acta Neurol Scand; 1996 Nov; 94(5):329-36. PubMed ID: 8947285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
    Fernandez HH; Trieschmann ME; Burke MA; Friedman JH
    J Clin Psychiatry; 2002 Jun; 63(6):513-5. PubMed ID: 12088163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine.
    Abdul-Rahman T; Herrera-Calderón RE; Aderinto N; Kundu M; Wireko AA; Adebusoye FT; Ekerin O; Lawal L; Mykolaivna NI; Alexiou A; Almashjary MN; Perveen A; Ashraf GM
    J Integr Neurosci; 2024 Apr; 23(4):80. PubMed ID: 38682215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.
    Scholz E; Dichgans J
    Eur Arch Psychiatry Neurol Sci; 1985; 235(1):60-4. PubMed ID: 2864254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.
    Factor SA; Friedman JH; Lannon MC; Oakes D; Bourgeois K;
    Mov Disord; 2001 Jan; 16(1):135-9. PubMed ID: 11215574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study.
    Friedman JH; Goldstein S; Jacques C
    Clin Neuropharmacol; 1998; 21(5):285-8. PubMed ID: 9789708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of quetiapine in Parkinson's patients with psychosis.
    Targum SD; Abbott JL
    J Clin Psychopharmacol; 2000 Feb; 20(1):54-60. PubMed ID: 10653209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics in Parkinson-sensitive populations.
    Friedman JH; Fernandez HH
    J Geriatr Psychiatry Neurol; 2002; 15(3):156-70. PubMed ID: 12230086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis.
    Sa DS; Kapur S; Lang AE
    Clin Neuropharmacol; 2001; 24(4):242-4. PubMed ID: 11479398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.